Who we are

MedaPhor Group plc is a global provider of advanced ultrasound education and training simulators for medical professionals.

Our lead product is ScanTrainer an ultrasound skills training simulator that teaches and assesses medical professionals hard to acquire  ultrasound scanning skills in a safe self-learn environment with minimal expert supervision and without the need for patients.

Overview

  • Aim Rule 26

    The following information is disclosed in accordance with Rule 26 of the AIM regulations Last updated: 6 July 2017.

  • Country of incorporation and main country of operation

    MedaPhor Group plc is incorporated and registered in England and Wales under the Companies Act 2006 with registered number 09028611. Our registered office is The Medicentre, Heath Park, Cardiff, Wales CF14 4UJ. The main country of operation is the UK.

  • Description of the business

    MedaPhor Group plc (AIM: MED) is a global provider of advanced ultrasound education and training simulators for medical professionals.

    The company’s lead product is the ScanTrainer ultrasound simulator training platform that assists students, doctors and sonographers to acquire ultrasound scanning skills, with minimal expert supervision and without the need of volunteer patients.

    In August 2016, MedaPhor acquired Inventive Medical Ltd and it’s product HeartWork which is a simulation used for teaching transthoracic and transesophageal ultrasound skills to medical professionals.

    MedaPhor Group plc was admitted to the AIM market on 27th August 2014.

  • Directors and committees

    For information about the Directors and Committees, click here

  • Current constitutional documents

  • Securities in issue

    Click here for more information about the number of securities in issue and, insofar as the Company is aware, the percentage of AIM securities not in public hands, together with the identity and percentage of significant shareholders.

  • Financial reports

    For access to the company’s Annual and Half-yearly reports, click here

  • Admission Document

    Click here to access the Admission

    Document in respect of the company’s admission to AIM on 27th August 2014

  • Advisors

    Click here for details of the Company’s advisors.

  • Corporate Governance

    The Board is accountable to the Company’s shareholders for maintaining high standards of Corporate Governance. The Directors acknowledge the principles set out in the Combined Code issued by the committee on Corporate Governance, although it does not comply with the Combined Code itself. The Board are committed to maintaining a high level of corporate governance in so far as it considered to be appropriate for a smaller quoted (AIM-listed) company.

  • Takeover Regulations

    MedaPhor Group plc is subject to the UK City Code on Takeovers and Mergers